FDA panel endorses first lower-cost biotech drug
Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Jan 7, 2015
0
10
Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Jan 7, 2015
0
10
The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.
Jan 2, 2015
0
12
Most Americans favor labeling calories on menus in fast food and sit-down restaurants. That's according to an Associated Press-GfK poll conducted in December that found most favor labels for prepared foods in the grocery ...
Dec 31, 2014
0
0
US authorities have given emergency authorisation to Swiss pharmaceutical firm Roche for an Ebola test that can take as little as three hours, the company said on Monday.
Dec 29, 2014
0
0
The U.S. Ebola response coordinator is calling the mishandling of materials that led to a lab technician's possible exposure to the virus "unacceptable."
Dec 28, 2014
0
0
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
0
1
The U.S. Food and Drug Administration is building a legal case against companies that sell pure powdered caffeine, which can be fatal even in small doses.
Dec 23, 2014
0
0
The Food and Drug Administration granted accelerated approval Monday to a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer.
Dec 22, 2014
0
0
The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.
Dec 20, 2014
0
0
Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.
Dec 19, 2014
0
0